Malignant Tumors
Kaposi Sarcoma
aka KS
Low-grade vascular malignancy caused by HHV-8 (KSHV); oral involvement is a defining lesion of AIDS, typically as purple palatal macules or nodules.
Virus
HHV-8
Site
Hard palate
Rx
ART + local therapy
§ overviewOverview
HHV-8-driven mesenchymal malignancy of endothelial origin producing multifocal vascular lesions of skin and mucosa.
§ icdICD Classification
C46
§ etiologyEtiology
- 01HHV-8 (KSHV) infection
- 02Cofactor: immunosuppression (HIV, transplant)
§ epidemiologyEpidemiology
AIDS-KS: >20 000× risk vs general population before ART; commonest HIV-associated malignancy.
§ clinicalClinical Features
- 01Flat red-purple macule → plaque → nodule
- 02Hard palate most common oral site, then gingiva, tongue
- 03Multifocal, painless initially → ulceration and bleeding
- 04Cutaneous, GI, pulmonary involvement in advanced disease
§ differentialDifferential Diagnosis
- 01Haemangioma
- 02Pyogenic granuloma
- 03Melanoma
- 04Bacillary angiomatosis
- 05Purpura
§ histopathHistopathology
- 01Proliferating spindle cells forming slit-like vascular spaces with extravasated RBCs
- 02Hyaline globules
- 03Plasma cell infiltrate
§ investigationsInvestigations
- 01Biopsy with HHV-8 IHC
- 02HIV testing and CD4 count
- 03CT chest/abdomen for staging
- 04Endoscopy if GI symptoms
§ ihcIHC / Special Stains
- 01HHV-8 LANA-1 positive (diagnostic)
- 02CD31, CD34, D2-40 positive
§ classificationClassification
- 01Classic (elderly Mediterranean)
- 02Endemic (African)
- 03Iatrogenic (post-transplant)
- 04AIDS-associated (epidemic)
§ treatmentTreatment
- 01Optimise ART (mainstay for AIDS-KS)
- 02Local: intralesional vinblastine, radiotherapy, cryotherapy, sclerotherapy
- 03Systemic: liposomal doxorubicin, paclitaxel for advanced disease
- 04Reduce immunosuppression in transplant-related KS
§ complicationsComplications
- 01Airway obstruction (laryngeal)
- 02Bleeding, disfigurement
- 03Systemic dissemination
§ prognosisPrognosis
AIDS-KS: dramatically improved with ART. Classic KS: indolent, elderly-appropriate care.
§ examKey Examination Points
- 01Purple palatal lesion → biopsy and HIV test
- 02Assess extent (skin, GI, pulmonary)
§ revisionQuick Revision Summary
- 01HHV-8 · palate · LANA-1+ · ART + local/systemic therapy
§ vivaBDS Viva Questions
- 01Aetiological agent of KS?
- 02Four clinical variants?
- 03Treatment of AIDS-KS?
§ mcqsMCQs — Assessment (3)
Question 1
Causative virus:
Question 2
Most common oral site:
Question 3
Diagnostic IHC marker:
References
- Cesarman E. Nat Rev Dis Primers 2019
Draft — pending faculty review. Educational use only; verify against current guidelines and primary sources before clinical application.